Literature DB >> 3511417

Anatomy and pathology of tubal pregnancy.

C J Pauerstein, H B Croxatto, C A Eddy, I Ramzy, M D Walters.   

Abstract

The prevalence of tubal pregnancy has increased markedly during the past decade. The reasons for this are obscure. A systematic gross and histopathologic study of 25 consecutive ectopic pregnancies has been performed using a clearing method not used previously for this purpose. In addition, the presence of the corpus luteum and its location in reference to the tubal pregnancy are documented. Results indicate that trophoblastic spread was predominantly intraluminal in 67% of cases. Intratubal hemorrhage, generally in parallel to trophoblastic spread, often led to marked tubal destruction. Histologic evidence of salpingitis was noted in only seven of 24 specimens (29%). The corpus luteum was contralateral to the ectopic pregnancy in five of 21 cases (23.8%). Clinical correlates and areas of future research are discussed. Results indicate that segmental resection of the tubal pregnancy is appropriate in selected cases.

Entities:  

Mesh:

Year:  1986        PMID: 3511417

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

1.  Attenuated tubal and endometrial urocortin 1 and corticotropin-releasing hormone receptor expression in ectopic pregnancy.

Authors:  L E Borges; A W Horne; S E McDonald; J L V Shaw; P C Lourenco; F Petraglia; H O D Critchley
Journal:  Reprod Sci       Date:  2010-10-26       Impact factor: 3.060

2.  Leucocyte populations in ectopic tubal pregnancy.

Authors:  U Earl; D P Lunny; J N Bulmer
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

3.  Pseudo-decidualization at the site of implantation in tubal pregnancy.

Authors:  U M Spornitz
Journal:  Arch Gynecol Obstet       Date:  1993       Impact factor: 2.344

4.  The relation between depth of trophoblastic invasion and beta-HCG levels in tubal pregnancies.

Authors:  M Klein; A Graf; H Kiss; K Czerwenka; A Beck; C Egarter; P Husslein
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.